Article
The IL23 axis plays a key role in the pathogenesis of IBD.
Gut - 1 Oct 2007
McGovern Dermot, Powrie Fiona
Abstract excerpt
Exciting new results from a genetic study in humans and functional studies in mice have pinpointed interleukin 23 (IL23) and its receptor as a key pathway in the pathogenesis of inflammatory bowel disease (IBD). These findings reveal a hitherto unappreciated role for the IL23 axis in intestinal inflammation and may open new avenues for development of therapeutic strategies in IBD.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
